drugset / Trial / NCT07163702
Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Ⅱa clinical trial. The purpose of this study is to preliminarily explore the optimal dosage of Xinglou Chengqi Granules in the treatment of acute ischemic stroke and to evaluate the efficacy and safety of Xinglou Chengqi Granules for acute ischemic stroke.
Timeline
- Start
- 2025-10-01
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xinglou Chengqi granules | Unknown | 8 g | Oral |
| Subject | Xinglou Chengqi granules | Unknown | 16 g | Oral |